Use

This test detects Parvovirus B19 DNA in plasma, which is especially important in immunocompromised or post‑transplant patients where infection may lead to serious complications, such as persistent anemia, myocarditis, or nephropathy. DNA testing provides reliable evidence of persistent infection and quantitative results can support response monitoring and transmission risk assessment.